BSECompany Update3d ago · 22 Sept 2026, 05:37 pm
Intimation of Disclosures
Evexia Lifecare Ltd · 524444
✦ AI SummaryPledge
Evexia Lifecare Ltd has received a disclosure from Shree Saibaba Exim Private Limited, a promoter group entity, regarding the purchase of 14,45,000 equity shares of Evexia Lifecare Limited on September 22, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment1/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Attachments (1)
📄pdf
Download →
95788310-cb1d-4458-bb68-e577f3d59b1f.pdf
View document text
eve:ia
EVEXIA LIFECARE LIMITED
(Formerly Known as Kavit Industries Ltd.)
Date: September 22, 2026
BSE Limited
P. ). Towers,
Dalal Street, Fort,
Mumbai- 400001
Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations,
2015
Dear Sir/Madam,
In accordance with the provisions of Regulation 7(2)(a) read with Regulation 6(2) of SEBI (Prohibition of
Insider Trading) Regulations, 2015, the Company has received disclosure on September 22, 2026 from
M/s. Shree Saibaba Exim Private Limited, Promoter Group with respect to the purchase of 14,45,000
equity shares of Evexia Lifecare Limited.
Please find enclosed herewith necessary disclosure under Regulation 7(2)(a) read with Regulation 6(2) of
SEBI (Prohibition of Insider Trading) Regulations, 2015.
Please take the same on your record.
Thanking you.
Yours faithfully,
For, EVEXIA LIFECAI
MANAGING DIRECTOR
(DIN: 01631093)
EncAsl A.bo:ve
Reg. Off. : Tundav Anjesar Raod, Vill. Tundav, Tal.: Savli, Vadodara - 391 775
Corporate Office : 9th Floor, Galav Chambers, Sayajigunj, Vadodara-390 020. Ph : +91 265 2361100 / 2200
CIN : L23100GJ1990PLC014692 Email : info@evexialifecare.com Web.: www.evexialifecare.com
Shree Saibaba Exim Private Limited
9™ Floor, Galav Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020
CIN - U51101GJ2013PTC077088
Email ID - s! ibabaexim2! il.com
Date: September 22, 2026
Managing Director,
EVEXIA LIFECARE LIMITED,
Vill : Tundao, Tal: Salvi Vadodara- 391775, Gujarat
Scrip Code: 524444
Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations,
2015.
Dear Sir/Madam,
This is with reference to the purchase of equity shares dated September 22, 2026.
This intimation is provided in terms of the provisions of Regulation 7(2)(a) of the SEBI Insider Trading
Regulations and all other applicable provisions of Securities and Exchange Board of India Act, 1992 and
applicable rules and regulations made thereunder.
This letter is intended for the Company’s information and records.
Thanking You.
Director
(DIN: 02480296)
Encl: As above
j|pg x S|oy
yunwej
oe ju8o
oue jo ob |m
oi wn do eu
y o|mJ
uyma
tq sx ae |pa
3/dnq
ua dx y9 |2
dxn aa |p
yaJaun ® oga 1/ o wera h yuqaJ- sa neusj x‘ asods 5&(
Zz-0
6o -d |e
wg |sd
0w ze 9I
xy r I|wuN
s i p f e
u o ) - (
) 9 u o n e
y w i
e a : ( z ) £
m a a
] S T 0 Z ‘
y ( S u r p e l
a p i s u j J
EAIHXIV
TI4EDVH3
TINILAQ
ISIN
oJ 31
dowdeuA: -
NAETEWOT0E0
.EEN eu
mvu.:._u_uu 0
J-&0!.2&:»53..
dlowojaJ
y.ond‘-ga
PUfl
fl.G EEA
ag Sd odm
yg e3a sId
Pne Io Lb
sA aI pMIL
NY a3
SIq Pe
ro 3J
1o ib pm
gae io sb om
usimou
syexas‘
)giowoj
sdajA
wL oAd wo |oj
Np Oe
d e|ao
I jN
|u3 %2
9N |LJ
ds na od un
y4da
dxow
1) r4
Jg n
ay j0e
esa/ s
o e2jp
BiuB
ns dy /e x p|a
ss ‘y e 3ras‘
asid
uy ep
ueMEIL'
as pye
x a|as‘
u ]ys‘
xys‘
ME I /LB
s) o0 uo u /|A
aD J0UA21J
YIA0
Iu ©jys‘
qnxa
JnqI
n) o0u
A /|2J
s/yu
rq ua ag pa
uq JagauJ
yuao
on eq |1s
rn ea aa
sn ‘aas‘
q na oq
a /|uj
xapep
aay r |SyS
gnsys
03a1
sn |aas‘
yo/o
ra yu
aaunpa
-dp aes
swo (ujs
mau“
aa pju Ap |pa
2u (au (q‘ )5E[
giowo
|mT uP
|T S'Y 0¥
|T mT '
- T0 |6-
ns dy
8s $yer
ss aye
rC aS
8z $02
906-
)9'0%#
)0°0L9
)9'121
2029
\‘vum/
) 1 9
3 S nerus
oj)ya
domudeu
qererpso
D udI QVN ‘N/
BASS
D0 MU N3
B9U 105
1E ‘2Iq
eL IA
WBNA
yraap
YVL dI
N80ON
yaayqss
1) 0y
0e ei
so sd
ee sd i8le
JmS (an
AEPOPEIB -
€600Z0‘
ynfezeJ
LLLVEL WZ
O6T9
uejf:syTaoseiqeqeo
NWzz@0zW
JWa0od
u oa
d x yn
- u+
6 1 0 7 ‘ s
s i o d - p o r e) 9 u o S ) u n J o( 7 1 5 3 0 ]
o n p n B a y ( B u u d i s o p - d n o a sn U lE P I U MO N ° s J a q u I n N S P E N U 0 I ) 1 z N
p n , 1 a p
1 o j o w o aU A SN N S Eo ( 2 1 2 s
a n f e A
s d o e z
u flo
u o n i
i o 4 d ) 1 4 3 5 0
J o J
a q u i
SHEsIoH-YINS-IOHO0-PuE
Q J o
a x m n g P e n
u o n
S ) u n J o J a
u( 3 2 1 5 1 0 ] + S P
( 1 ) u o n p i n G a u s a p u n p a u i f o p
s B u j u p a t i a y 3
4 D Y [ [ D Y S S A H N 2 2 S , ( ) = 1 0 8
s a B a p y p 1 2 1 3 0 A u n / a b p . 1 2 3 0
4 q / 5 9 X D 3 S A P N J I
X 2 U O N I D S U D . L ] , o a n o p ( 1 )
A q Aw u e d- m o d2 3 y Jo O S S3 N L Ie N
U 0 Se I A Rd
I I UP I S u i p je o n s p e z a q
S 0 - S O A T E I O
p o u s E p U e
jd o a d A ) A 3 p a d s ) s a a n e a r I a
p u r S u r p e l L
A n g
P E N U )
e n u o d J o 3 d A L
n N [ e u o n o N
s u o n e s y p a d s
U 0 D ) a n e A 8 T
N N W I X G E q E Q I E S I Y S : w E N
B Y q U s I A E F U I q I I Y Y S n o y L J 0 p 2 0 1 q ( 9 6 2 0 8 2 7 0 * N I Q ) 9 2 0 ‘2 z z 1 o q u i s i :d aa rs e q B I E P O P E A : 3 0 8 [ d
Shree Saibaba Exim Private Limited
9 Floor, Galay Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020
CIN - U51101GJ2013PTC077088
Email ID - s@%gbuximlfl@nfl.gm
Date: 22/09/2026
To, To,
The Department of Corporate Service, The Board of Directors,
BSE Limited, EVEXIA LIFECARE LIMITED,
Phiroze Jeejeebhoy Tower, Vill: Tundao, Tal: Salvi Vadodara-391775,
Dalal Street, Mumbai-400 001. Gujarat
Scrip Code: 524444
Dear Sir/Madam,
Subject: Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011
This is with reference to the disclosure enclosed herewith as required to be made upon purchase of
shares of Evexia Lifecare Limited under Regulation 29(2) of SEBI (Substantial Acquisition of Shares
and Takeovers) Regulations, 2011.
Kindly take the above information on record.
Thanking you,
Yours faithfully,/
Name: Shfee Saibaba Exim Private Limited
Through Artiben Jayeshbhai Thakkar
Director
(DIN: 02480296)
CC To:
EVEXIA LIFECARE LIMITED (For information and record)
Vill : Tundao, Tal: Salvi Vadodara-391775, Gujarat
Encl: as above
Annexure 1
Disclosures under Regulation 29(2) of SEBI (Substantial A ition of Shares and Takeovers
Regulations, 2011
Name of the Target Company (TC) EVEXIA LIFECARE LIMITED
Name(s) of the acquirer/SeHer and Persons Acting in M/s. Shree Saibaba Exim Private Limited
Concert (PAC) with the acquirer/Seler
Whether the acquirer/Seller belongs to | Yes (Promoter Group)
Promoter/Promoter group
Name(s) of the Stock Exchange(s) where the shares of | BSE Limited
TC are Listed
Details of the acquisition / dispesat as follows Number % w.r.t. total % w.r.t.
share/voting total diluted
capital share/voting
wherever capital of
applicable(*) | the TC (**)
Before the acquisition / dispesal under
consideration, holding of :
a) Shares carrying voting rights 11,34,67,585 6.044% 6.044%
b) Shares in the nature of encumbrance (pledge/ lien/
non-disposal undertaking/ others) 0 0.00% 0.00%
¢) Voting rights (VR) otherwise than by shares 0 0.00% 0.00%
d) Warrants/convertible securities/any other
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) 0 0.00% 0.00%
Total (a+b+c+d) 11,34,67,585 6.044% 6.044%
Details of acquisition/sale
a) Shares carrying voting rights acquired/seld 14,45,000 0.076% 0.076%
b) VRs acquired/sold otherwise than by shares 0 0.00% 0.00%
¢) Warrants/convertible securities/any other 0 0.00% 0.00%
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) acquired/sold
d) Shares encumbered / invoked/released by the 0 0.00% 0.00%
acquirer/seller
Total (a+b+c+d)
14,45,000 0.076% 0.076%
After the acquisition/sale, holding of:
a) Shares carrying voting rights
b) Shares encumbered with the acquirer/seller 0.00% 0.00%
¢) VRs otherwise than by shares 0.00% 0.00%
d) Warrants/convertible securities/any other 0.00% 0.00%
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) after aequisition/sale
Total (a+b+c+d) 11,49,12,585 6.121% 6.121%
Mode of acquisition/sale (e.g. open market / eff-market Open Market
+—publie—issue—/—rights—issue /preferential-allotment/
inter-se-transeftce.r)
Date of acquisition / sale-ef-shares—-—VRordate—of September 22, 2026
receipt-of-intimation-of allotment-of shares, whichever
is applicable
Equity share capital / total vo
[Showing first 8,000 characters — download PDF for full document]